Autopsy report · NCT01248299
Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.
Cause of deathNo reason given
Life of this trial
- Registered 2 months before it started.
- Ran for about 6 years before it stopped.
- 105 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Centre Oscar Lambret
- Sponsor type
- University, hospital or other
- Conditions
- Squamous Cell Carcinoma of Esophagus
- Interventions
- FU-CDDP; LV5FU2-CDDP; FOLFOX; TPF; Best Supportive Care
- Participants
- 105
- Sites
- 17
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.